PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3

[1]  Lin Qiu,et al.  PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling , 2021, Nature Communications.

[2]  Pengcheng Jiang,et al.  The Exocrine Differentiation and Proliferation Factor (EXDPF) Gene Promotes Ovarian Cancer Tumorigenesis by Up-Regulating DNA Replication Pathway , 2021, Frontiers in Oncology.

[3]  Li Yu,et al.  AML1-ETO inhibits acute myeloid leukemia immune escape by CD48 , 2020, Leukemia & lymphoma.

[4]  Jeffrey S. Miller,et al.  Exploring the NK cell platform for cancer immunotherapy , 2020, Nature Reviews Clinical Oncology.

[5]  J. Marioni,et al.  ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung , 2020, Nature Immunology.

[6]  J. Galon,et al.  Tumor Immunology and Tumor Evolution: Intertwined Histories. , 2020, Immunity.

[7]  Chun-Wei Peng,et al.  miR-100-3p inhibits cell proliferation and induces apoptosis in human gastric cancer through targeting to BMPR2 , 2019, Cancer Cell International.

[8]  E. Smit,et al.  How to Make the Best Use of Immunotherapy as First-Line Treatment for Advanced/Metastatic Non-Small-Cell Lung Cancer. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Guohua Liu,et al.  Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer. , 2019, Biochemical and biophysical research communications.

[10]  D. Olive,et al.  Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function , 2019, Front. Immunol..

[11]  Xin Fan,et al.  Pancreatic progenitor cell differentiation and proliferation factor predicts poor prognosis in heptaocellular carcinoma , 2019, Medicine.

[12]  I. Holen,et al.  Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment , 2019, Clinical Cancer Research.

[13]  K. D. de Visser,et al.  Cancer‐Cell‐Intrinsic Mechanisms Shaping the Tumor Immune Landscape , 2018, Immunity.

[14]  Jennifer R. Grandis,et al.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer , 2018, Nature Reviews Clinical Oncology.

[15]  N. Cacalano.  Regulation of Natural Killer Cell Function by STAT3 , 2016, Front. Immunol..

[16]  John Gilleran,et al.  Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death , 2016, Molecular Cancer.

[17]  N. Morrell,et al.  Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension. , 2015, American journal of respiratory and critical care medicine.

[18]  M. Merad,et al.  The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. , 2015, American journal of respiratory and critical care medicine.

[19]  H. Moses,et al.  BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation , 2015, Molecular oncology.

[20]  Wei Guo,et al.  BMPR2 inhibition induced apoptosis and autophagy via destabilization of XIAP in human chondrosarcoma cells , 2014, Cell Death and Disease.

[21]  Z. Tian,et al.  NK Cells Are the Crucial Antitumor Mediators When STAT3-Mediated Immunosuppression Is Blocked in Hepatocellular Carcinoma , 2014, The Journal of Immunology.

[22]  Lushan Wang,et al.  Investigating the Impact of Asp181 Point Mutations on Interactions between PTP1B and Phosphotyrosine Substrate , 2014, Scientific Reports.

[23]  Z. Tian,et al.  Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions via Reverse Hepatocellular Carcinoma–Induced Immune Suppression , 2013, Molecular Cancer Therapeutics.

[24]  D. Noonan,et al.  The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. , 2013, Neoplasia.

[25]  I. Frahm,et al.  Targeting Stat3 Induces Senescence in Tumor Cells and Elicits Prophylactic and Therapeutic Immune Responses against Breast Cancer Growth Mediated by NK Cells and CD4+ T Cells , 2012, The Journal of Immunology.

[26]  Shengyu Wang,et al.  A monoclonal antibody against the catalytic domain of PTP1B. , 2012, Hybridoma.

[27]  Kenji Mizuguchi,et al.  Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis. , 2012, Cancer research.

[28]  P. Validire,et al.  Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. , 2011, Cancer research.

[29]  X. Pivot,et al.  Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells. , 2011, Cancer research.

[30]  S. Lipton,et al.  Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. , 2010, Molecular cell.

[31]  Yuchun Luo,et al.  Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β* , 2009, The Journal of Biological Chemistry.

[32]  H. Katus,et al.  GDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent stabilization of XIAP. , 2009, Biochimica et biophysica acta.

[33]  D. Raulet,et al.  Oncogenic stress sensed by the immune system: role of natural killer cell receptors , 2009, Nature Reviews Immunology.

[34]  W. Pao,et al.  KRAS mutations in non-small cell lung cancer. , 2009, Proceedings of the American Thoracic Society.

[35]  Shuo Lin,et al.  Exdpf Is a Key Regulator of Exocrine Pancreas Development Controlled by Retinoic Acid and ptf1a in Zebrafish , 2008, PLoS biology.

[36]  H. Beppu,et al.  Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation , 2008, Oncogene.

[37]  Bianca Sperl,et al.  Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. , 2006, Chemistry & biology.

[38]  H. Andersen,et al.  Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. , 2005, Journal of molecular endocrinology.

[39]  R. Trembath,et al.  Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.

[40]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[41]  E. Aktas,et al.  Relationship between CD107a expression and cytotoxic activity. , 2009, Cellular immunology.